, « Législations relatives à l'usage et à la détention de cannabis : définitions et état des lieux en Europe-Note de synthèse-OFDT, 2017.

, Cannabis-Synthèse des connaissances-OFDT

, Code de la santé publique-Article R5132-86, R5132-86 Code de la santé publique § (s. d.). Consulté le 14 décembre, 2017.

U. «-en, le cannabis s'achète désormais en pharmacie » Lemonde.fr. Consulté le 15 décembre, 2017.

J. M. Raymond, M. W. Niesink, and . Van, Laar Does Cannabidiol Protect Against Adverse Psychological Effects of THC? Front Psychiatry, vol.4, p.130, 2013.

J. Goullé, E. Saussereau, and C. Lacroix, « Pharmacocinétique du delta-9tétrahydrocannabinol (THC)

G. G. Nahas, « The Pharmacokinetics of THC in Fat and Brain: Resulting Functional Responses to Marihuana Smoking, Human Psychopharmacology, vol.16, issue.3, pp.247-55, 2001.

, « Cannabis : quels effets sur le comportement et la santé ». INSERM Consulté le 16 décembre 2017

K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, and B. R. Chaitman, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Epidemiology (STROBE)statement: guidelines for reporting observational studies, Lancet, vol.370, issue.9596, pp.1453-1460, 2007.

K. F. Schulz, D. G. Altman, D. Moher, . Group, and . Consort, Statement: updated guidelines for reporting parallel group randomised trials, BMC Medicine, vol.8, p.18, 2010.

, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), European Heart Journal, vol.39, issue.2, pp.119-177, 2017.

G. Collomb and . Le-figaro, Cannabis : pas de dépénalisation mais une amende forfaitaire

S. Arora, H. Goyal, P. Aggarwal, A. Et, and . Kukar, « ST-Segment Elevation Myocardial Infarction in a 37-Year-Old Man with Normal Coronaries-it Is Not Always Cocaine!, The American Journal of Emergency Medicine, vol.30, issue.9, pp.2091-2094

L. Bachs and H. Mørland, « Acute cardiovascular fatalities following cannabis use, Forensic Science International, vol.124, issue.2, pp.200-203, 2001.

C. Bailly, O. Merceron, N. Hammoudi, R. Dorent, and P. Michel, « Cannabis induced acute coronary syndrome in a young female, International Journal of Cardiology, vol.143, issue.1, pp.4-6

A. Podczeck, K. Frohner, K. Et, and . Steinbach, « Acute myocardial infarction in juvenile patients with normal coronary arteries, International Journal of Cardiology, vol.30, pp.359-61

D. Renard, G. Taieb, G. Gras-combe, and P. Labauge, « Cannabis-Related Myocardial Infarction and Cardioembolic Stroke, Journal of Stroke and Cerebrovascular Diseases, vol.21, issue.1, pp.82-83, 2012.

A. M. Safaa, R. Markham, and . Et-rohan-jayasinghe, « Marijuana-Induced Recurrent Acute Coronary Syndrome with Normal Coronary Angiograms, Drug and Alcohol Review, vol.31, issue.1, pp.91-94, 2012.

M. Sayin, I. Rasit, . Akpinar, A. Mehmet, . Cetiner et al.,

, Who Is Guilty? Cannabis, Smoking or Dyslipidemia?/Genc Bir Erkekte Yaygin Koroner Ektazi ve Akut Koroner Sendrom. Suclu Kim? Esrar, Sigara Ya Da Dislipidemi?, « Diffuse Coronary Ectasia and Acute Coronary Syndrome in a Young Man, pp.1-2013

J. Schmid and J. Auer, « Spontaneous coronary artery dissection in a young man-Case report, Journal of Cardiothoracic Surgery, vol.6, p.22

M. Shah, J. Garg, B. Patel, J. Guthier, and R. S. Freudenberger, « Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus, International Journal of Cardiology, vol.215, pp.129-160

D. Sürder, N. Kucher, F. R. Eberli, and M. Roffi, « Intracoronary thrombus in a 26-year-old man, European Heart Journal, vol.27, issue.1, pp.2631-2631, 2006.

A. T. Taher1, A. R. Rami, . Mahfouz2, K. Zaher, A. G. Otrock1 et al.,

I. Jaber, Sawaya 2. « Acute Myocardial Infarction in a Young Man: A Consequence of Inherited Thrombophilia and Marijuana Smoking, Thrombosis and Haemostasis, vol.95, issue.6, pp.1044-1044, 2006.

E. Tatli and M. Y?lmaztepe, Gurcan Altun, et Armagan Altun. « CannabisInduced Coronary Artery Thrombosis and Acute Anterior Myocardial Infarction in a Young Man, International Journal of Cardiology, vol.120, issue.3, pp.420-442, 2007.

R. Tse, S. Kodur, B. Squires, and N. Collins, « Sudden Cardiac Death Complicating Acute Myocardial Infarction Following Synthetic Cannabinoid Use, Internal Medicine Journal, vol.44, issue.9, pp.934-970
DOI : 10.1111/imj.12521

E. Ul-haq, A. Shafiq, A. A. Khan, A. A. Awan, S. Ezad et al.,

«. Spice, Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series, Case Reports in Cardiology, 2017.

Y. Velibey and S. Sahin,

M. Eren, « Acute Myocardial Infarction Due to Marijuana Smoking in a Young Man: Guilty Should Not Be Underestimated, The American Journal of Emergency Medicine, vol.33, issue.8, 2015.

S. Y?lmaz and S. Ünal, Mevlüt Serdar Kuyumcu

B. Mustafa-mücahit, « Acute anterior myocardial infarction after "Bonzai" use

, Anatolian Journal of Cardiology, vol.15, issue.3, pp.265-66, 2015.

M. Yurtda? and . Mehmet-kas?m-ayd?n, « Acute Myocardial Infarction in a Young Man; Fatal Blow of the Marijuana: A Case Report, Korean Circulation Journal, vol.42, issue.9, pp.641-686

S. Zaleta, P. Kumar, S. Et, and . Miller, « Chest pain, troponin rise, and STelevation in an adolescent boy following the use of the synthetic cannabis product K2, Annals of Pediatric Cardiology, vol.9, issue.1, pp.79-81, 2016.

E. Jouanjus, F. Leymarie, M. Tubery, and . Et-maryse-lapeyre-mestre,

«. Cannabis, Related Hospitalizations: Unexpected Serious Events Identified through Hospital Databases, British Journal of Clinical Pharmacology, vol.71, issue.5, pp.758-65, 2011.

E. Jouanjus, M. Lapeyre-mestre, and J. Micallef, « Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol.3, issue.2

P. P. Thankavel, A. Mir, C. Et, and . Ramaciotti, « Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen, Cardiology in the Young, vol.24, issue.2, pp.283-89, 2014.

M. A. Mittleman, R. A. Lewis, and M. Maclure,

J. E. Muller, « Triggering Myocardial Infarction by Marijuana, Circulation, vol.103, issue.23, pp.2805-2814

T. S. Nawrot, L. Perez, and N. Künzli, Elke Munters, et Benoit Nemery. « Public health importance of triggers of myocardial infarction: a comparative risk assessment, The Lancet, vol.377, pp.732-772

S. Sidney, J. E. Beck, C. Tekawa, G. Quesenberry, and . Friedman, « Marijuana use and mortality, American Journal of Public Health, vol.87, issue.4, pp.585-90, 1997.

S. Sidney and . Cardiovascular, Consequences of Marijuana Use Volume42, Issue S1, pp.64-70, 2002.

J. P. Reis, R. Auer, M. P. Bancks, D. C. Goff, C. E. Lewis et al., « Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study », American Journal of Public Health, vol.107, issue.4, pp.601-607

R. , D. Patel, U. Sharma, S. Amin, P. Bhuva et al.,

, « Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide Inpatient Sample in the United States, vol.9

A. Kalla, P. Krishnamoorthy, A. Gopalakrishnan, J. Garg, and V. Figueredo, CANNABIS USE PREDICTS RISKS OF HEART FAILURE AND CEREBROVASCULAR ACCIDENTS: RESULTS FROM THE NATIONAL INPATIENT SAMPLE, vol.69, p.1784, 2017.

A. Chami, . Tarek, C. Et, .. Kim, and . Infarction, A POPULATION BASED STUDY ». Journal

, American College of Cardiology (ACC) Annual Scientific Sessions, vol.69, issue.11, p.6, 2017.

M. Afshar, N. Karki, P. Chernek, P. Thet, B. Sapkota et al.,

M. Magar, S. Ameen, . Chilimuri, J. Et, and . Bella, « Relationship Between Marijuana Use and Hospitalization for Acute Coronary Syndrome, Journal of the American College of Cardiology, vol.69, issue.11, p.84

E. I. Draz, M. Mervat, E. A. Oreby, L. A. Elsheikh, . Khedr et al., « Marijuana use in acute coronary syndromes, The American Journal of Drug and Alcohol Abuse, vol.43, issue.5, pp.576-82

U. Vinsonneau, P. Castellant, R. Didier, P. Nicol, M. Herault et al., Evaluation of cannabis abuse and epidemiology in 61 young adults aged less than 35 years old hospitalized for acute coronary syndrome ». Archives of Cardiovascular Diseases Supplements, 25es Journées Européennes de la Société Française de Cardiologie-14-17 janvier 2015-Palais des Congrès, vol.0124, pp.7-8

K. J. Mukamal, M. Maclure, J. E. Muller, and M. A. Mittleman, « An Exploratory Prospective Study of Marijuana Use and Mortality Following Acute Myocardial Infarction, American heart journal, vol.155, issue.3, pp.465-70, 2008.

L. Frost, E. Mostofsky, J. I. Rosenbloom, and K. J. Mukamal,

M. A. Mittleman, « Marijuana use and long-term mortality among survivors of acute myocardial infarction, American Heart Journal, vol.165, issue.2, pp.170-75, 2013.

C. P. Johnson-sasso, D. Kao, L. A. Et, and . Walker, MARIJUANA USE AND SHORT-TERM OUTCOMES IN PATIENTS HOSPITALIZED FOR ACUTE

M. Infarction-», Journal of the American College of Cardiology, vol.67, p.569

H. Isbell, C. W. Gorodetzsky, D. Jasinski, U. Claussen, F. Spulak et al., « Effects of Delta-9-Trans-Tetrahydrocannabinol in Man, Psychopharmacologia, vol.11, issue.2, pp.184-88, 1967.

P. Beaconsfield, J. Ginsburg, R. Et, and . Rainsbury, Marihuana Smoking, vol.287, pp.209-221
DOI : 10.1056/nejm197208032870501

J. L. Weiss, A. M. Watanabe, L. Lemberger, I. M. Galanter, R. J. Wyatt et al., Cardiovascular effects of delta-9-tetrahydrocannabinol in man, Clin Pharmacol Ther, vol.286, issue.13, pp.671-84, 1972.

S. C. Clark, C. Greene, G. W. Karr, K. L. Maccannell, and S. L. Milstein,

, « Cardiovascular Effects of Marihuana in Man, Canadian Journal of Physiology and Pharmacology, vol.52, pp.706-725

S. Johnson and E. F. Domino, « Some Cardiovascular Effects of Marihuana Smoking in Normal Volunteers, Clinical Pharmacology & Therapeutics, vol.12, pp.762-68

N. L. Benowitz, J. Rosenberg, W. Rogers, J. Bachman, and R. T. Jones,

, « Cardiovascular Effects of Intravenous Delta-9-Tetrahydrocannabinol: Autonomic Nervous Mechanisms, vol.25, pp.440-486, 1979.

R. Prakash, W. S. Aronow, M. Warren, W. Laverty, and L. A. Gottschalk, « Effects of Marihuana and Placebo Marihuana Smoking on Hemodynamics in Coronary Disease, Clinical Pharmacology & Therapeutics, vol.18, issue.1, pp.90-95

D. P. Tashkin, J. A. Levisman, A. S. Abbasi, B. J. Shapiro, and N. M. Ellis, « ShortTerm Effects of Smoked Marihuana on Left Ventricular Function in Man, Chest, vol.72, issue.1, pp.20-26

P. F. Renault, R. Charles, D. X. Schuster, B. Freedman, D. Sikic et al., et Angelos Halaris. « Repeat Administration of Marihuana Smoke to Humans, vol.31, pp.95-102

L. A. Malit, R. E. Johnstone, D. I. Bourke, R. A. Kulp, V. Klein et al., « Intravenous Delta9-Tetrahydrocannabinol: Effects of Ventilatory Control and Cardiovascular Dynamics, Anesthesiology, vol.42, issue.6, pp.666-73

R. T. Jones, N. Benowitz, and J. Bachman, Clinical studies of cannabis tolerance and dependence, Ann. N. Y. Acad. Sci, vol.282, p.221, 1976.

R. T. Jones, N. L. Benowitz, and R. I. Herning, Clinical relevance of cannabis tolerance and dependence, J. Clin. Pharmacol, vol.21, p.143, 1981.

N. L. Benowitz, R. T. Et, and . Jones, « Cardiovascular and Metabolic Considerations in Prolonged Cannabinoid Administration in Man, The Journal of Clinical Pharmacology, vol.21, pp.214-223

C. Kanakis, M. Pouget, and K. M. Rosen, Lack of cardiovascular effects of delta-9tetrahydrocannabinol in chemically denervated men, Ann Intern Med, vol.91, pp.571-574, 1979.

L. L. Ponto, D. S. Boles, J. O'leary, R. I. Koeppel, G. L. Block et al.,

E. Schmitt, D. Richard, and . Hichwa, « Effect of Acute Marijuana on Cardiovascular Function and Central Nervous System Pharmacokinetics of [15O]Water: Effect in Occasional and Chronic Users, The Journal of Clinical Pharmacology, vol.44, issue.7, pp.751-66

C. Kanakis, J. M. Pouget, and K. M. Rosen, The effects of Delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade, Circulation, vol.53, pp.703-707, 1976.

A. Gash, J. S. Karliner, D. Janowsky, and C. R. Lake, Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men, Ann Intern Med, vol.89, pp.448-452, 1978.

M. S. Kochar and M. J. Hosko, Electrocardiographic effects of marihuana, JAMA, vol.225, pp.25-27, 1973.

W. T. Roth, J. R. Tinkleinberg, B. S. Kopell, and L. E. Hollister, Continuous electrocardiographic monitoring during marihuana intoxication, Clin Pharmacol Ther, vol.14, pp.533-540, 1973.

W. S. Aronow, J. Et, and . Cassidy, « Effect of Marihuana and Placebo-Marihuana Smoking on Angina Pectoris, New England Journal of Medicine, vol.291, issue.2, pp.65-67

W. S. Aronow and J. Et, Cassidy « Effect of Smoking Marihuana and of a HighNicotine Cigarette on Angina Pectoris, Clinical Pharmacology & Therapeutics, vol.17, pp.549-54

A. ;. Bonz, . Laser, ;. Martin, S. ;. Küllmer, . Kniesch et al., Jörg *

V. ;. Popp, G. ;. Ertl, and . Wagner, Jens Andreas Cannabinoids Acting on, p.1

, Receptors Decrease Contractile Performance in, Human Atrial Muscle Journal of Cardiovascular Pharmacology, vol.41, pp.657-664, 2003.

E. A. Formukong, A. T. Evans, and F. J. Evans, « The Inhibitory Effects of Cannabinoids, The Active Constituents of Cannabis Sativa L. on Human and Rabbit Platelet Aggregation, Journal of Pharmacy and Pharmacology, vol.41, issue.10, pp.705-714

R. Levy, A. Schurr, I. Nathan, A. Dvilanski, and A. Livne, Impairment of ADPinduced platelet aggregation by hashish components, Thromb Haemost, vol.36, pp.634-674, 1976.

E. Deusch, H. G. Kress, B. Kraft, S. A. Et, and . Kozeklangenecker, The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets ». Anesthesia & Analgesia 99, p.1127, 2004.

V. De-angelis, A. C. Koekman, C. Weeterings, M. Roest, P. G. De-groot et al., Endocannabinoids control platelet activation and limit aggregate formation under flow, PLoS One, vol.9, issue.9, p.108282, 2014.

M. &. Catani, V. &. Gasperi, G. &. Catanzaro, . Baldassarri, A. &. Bertoni et al., Human Platelets Express Authentic CB1 and CB2 Receptors, Current neurovascular research, vol.7, pp.311-319, 2010.

D. Heiden, R. Rodvien, and R. Jones, Effects of oral delta-9-tetrahydroicannabinol on coagulation, Thromb Res, vol.17, pp.885-894, 1980.

J. C. Williams, W. Thomas, B. A. Klein, J. W. Goldberger, N. Sleasman et al., « ?9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocytederived microvesicles », Journal of Inflammation, p.12

K. Sugamura, S. Sugiyama, and T. Nozaki, Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages, Circulation, vol.119, pp.28-36, 2009.

K. H. Han, S. Lim, and J. Ryu, CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages, Cardiovasc Res, vol.84, pp.378-386, 2009.

M. Yuan, S. M. Kiertscher, and Q. Cheng, Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells, J Neuroimmunol, vol.133, pp.124-131, 2002.

M. Rajesh, P. Mukhopadhyay, and S. Batkai, CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion, Am J Physiol Heart Circ Physiol, vol.293, pp.2210-2218, 2007.

M. Rajesh, P. Mukhopadhyay, and G. Hasko, Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and-independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells, Br J Pharmacol, vol.160, pp.688-700, 2010.

M. Rajesh, P. Mukhopadhyay, and G. Hasko, CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration, Br J Pharmacol, vol.153, pp.347-357, 2008.

M. Rajesh, P. Mukhopadhyay, and G. Hasko, Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation, Biochem Biophys Res Commun, vol.377, pp.1248-1252, 2008.

S. E. Nissen, S. J. Nicholls, and K. Wolski, Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial, JAMA, vol.299, pp.1547-1560, 2008.

O. Leary, D. H. Reuwer, A. Q. Nissen, and S. E. , Effect of rimonabant on carotid intimamedia thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR trial, Heart, vol.97, pp.1143-1150, 2011.

E. J. Topol, M. G. Bousser, and K. A. Fox, Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial, Lancet, vol.376, pp.517-523, 2010.

P. Korantzopoulos, T. Liu, and D. Papaioannides, Atrial fibrillation and marijuana smoking, Int J Clin Pract, vol.62, pp.308-313, 2008.
DOI : 10.1111/j.1742-1241.2007.01505.x

D. A. Kosior, K. J. Filipiack, P. Stolarz, and G. Opolski, Paroxymal atrial fibrillation in ayong female patient following marihuana intoxication-a case report of possible association, Med Sci Monit, vol.6, pp.386-395, 2000.

G. K. Sing, Atrial fibrillation associated with marijuana use, Pediatr Cardiol, vol.21, issue.3, p.284, 2000.

B. Fisher, A. Ghuran, V. Vadamalai, and T. F. Antonios, Cardiovascular complications induced by cannabis smoking: a case report and review of literature, 2005.

, Emerg Med J, vol.22, pp.679-680

, SamuelMenahem Cardiac asystole following cannabis (marijuana) usageAdditional mechanism for sudden death?, Forensic Sci Int, vol.233, issue.1-3, pp.3-5, 2013.

A. J. Romero-puche, N. Trigueros-ruiz, C. Mc, F. Perez-lorente, D. Roldan et al., Brugada electrocardiogram pattern induced by cannabis, Rev Esp Cardiol, vol.65, issue.9, pp.856-864, 2012.

S. H. Rezkalla, P. Sharma, and R. A. Kloner, Coronary no-flow and ventricular tachycardia associated with habitual marijuana use, Ann Emerg Med, vol.42, issue.3, pp.365-374, 2003.

X. Wang and S. Nie, The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovascular Diagnosis and Therapy, vol.1, pp.37-43, 2011.

A. R. Erbay, H. Turhan, and K. Senen, Documentation of slow coronary flow by the thrombolysis in myocardial infarction frame count in habitual smokers with angiographically normal coronary arteries, Heart Vessels, vol.19, pp.271-274, 2004.

J. A. Wagner, M. Abesser, and J. Karcher, Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts, J Cardiovasc Pharmacol, vol.46, pp.348-355, 2005.

P. Morales, D. P. Hurst, and P. H. Reggio, Molecular Targets of the Phytocannabinoids: A Complex Picture, 2017.

J. Kobayashi, Phytocannabinoids. Progress in the Chemistry of Organic Natural Products, vol.103

T. Wu, D. P. Tashkin, B. Dhahed, and J. E. Rose, Pulmonary hazards of smoking marijuana as compared with tobacco, New England Journal of Medicine, vol.318, issue.6, pp.347-351, 1988.

H. Shereif, Coronary no-flow and ventricular tachycardia associated with habitual marijuana use Rezkalla, Annals of Emergency Medicine, vol.42, issue.3, pp.365-369

R. N. Khouzam and R. Kabra, et Mohamad Khaled Soufi. « Marijuana, bigeminal premature ventricular contractions and sluggish coronary flow: Are they related?, Journal of Cardiology Cases, vol.8, pp.121-145

M. A. Huestis, A. Barnes, and L. Michael, Smith « Estimating the Time of Last Cannabis Use from Plasma ? 9-Tetrahydrocannabinol and 11-nor-9-Carboxy-? 9Tetrahydrocannabinol Concentrations, Clinical Chemistry, vol.51, issue.12, pp.2289-2295, 2005.

N. N. Singh, Y. Pan, S. Muengtaweeponsa, T. J. Geller, and S. Cruz-flores, Cannabis-related stroke: case series and review of literature, J Stroke Cerebrovasc Dis, vol.21, pp.555-560, 2012.

I. Mateo, A. Pinedo, M. Gomez-beldarrain, J. M. Basterretxea, and J. C. Garcia-monco, Recurrent stroke associated with cannabis use, J Neurol Neurosurg Psychiatr, vol.76, pp.435-437, 2005.

J. Finsterer, P. Christian, and W. K. , Occipital stroke shortly after cannabis consumption, Clin Neurol Neurosurg, vol.106, pp.305-308, 2004.

D. Barnes, J. Palace, O. Brien, and M. D. , Stroke following marijuana smoking, Stroke, vol.23, p.1381, 1992.

A. F. Santos, M. Rodriguez, . Mare´rmare´r, C. Ferreira, J. Soares-fernandes et al., Recurrent stroke in a young cannabis user, J Neuropsychiatry Clin Neurosci, vol.26, issue.1, pp.41-42, 2014.

A. N. Westover, S. Mcbride, and R. W. Haley, Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients, Arch Gen Psychiatry, vol.64, pp.495-502, 2007.

V. Wolff, V. Lauer, and O. Rouyer, Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction a prospective study in 48 consecutive young patients, Stroke, vol.42, pp.1778-80, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00676840

V. Wolff, I. Zinchenko, V. Quenardelle, and O. Rouyer, Bernard Geny Characteristics and Prognosis of Ischemic Stroke in Young Cannabis Users Compared With Non-Cannabis Users Journal of the American College of Cardiology, vol.66, p.2053, 2015.

S. Geibprasert, M. Gallucci, and T. Krings, Addictive illegal drugs: structural neuroimaging, AJNR Am J Neuroradiol, vol.31, pp.803-811, 2010.

I. Peyrot, A. M. Garsaud, I. Saint-cyr, O. Quitman, B. Sanchez et al., Cannabis arteritis: a new case report and a review of literature, J Eur Acad Dermatol Venereol, vol.21, pp.388-391, 2007.

G. L. Ambrecht, M. L. Malbrain, P. Coremans, L. Verbist, and H. Verhaegen, Acute renal infarction and heavy marijuana smoking, Nephron, vol.70, pp.494-496, 1995.

F. Corvi, G. Querques, R. Lattanzio, C. Preziosa, M. B. Parodi et al., Central retinal vein occlusion in a young patient following cannabis smoke inhalation, Eur J Ophthalmol, vol.24, issue.3, pp.437-477, 2014.

F. Cascini, C. Aiello, D. Tanna, and G. , Increasing delta-9-tetrahydrocannabinol (?-9-THC) content in herbal cannabis over time: systematic review and meta-analysis, Curr Drug Abuse Rev, vol.5, issue.1, pp.32-40, 2012.

M. A. Elsohly, Z. Mehmedic, S. Foster, C. Gon, S. Chandra et al.,

. Decades, Analysis of Current Data in the United States ». Cannabinoids and Psychotic Disorders 79, pp.613-632, 1995.

, Understanding the 'Spice' phenomenon. Luxembourg: Office for Official Publications of the European Communities: EMCDDA, 2009.

K. A. Seely, J. Lapoint, and J. H. Moran, Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids, Prog Neuropsychopharmacol Biol Psychiatry, vol.39, pp.234-243, 2012.

S. D. Banister, Pharmacology of indole and indazole synthetic cannabinoid designer drugs, ACS Chem. Neurosci, vol.6, pp.1546-1559, 2015.

M. Chmelikovaa, L. Pacala, and L. Spinarovab, Anna Vaskua Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, vol.159, issue.4, pp.535-539, 2015.

H. Ait-oufella and A. Tedgui, Ziad Mallat L'athérosclérose : une maladie inflammatoire Sang Thrombose Vaisseaux, vol.20, pp.25-33, 2008.

M. C. Staiculescu, C. Foote, G. A. Meininger, and L. A. Martinez-lemus, The Role of Reactive Oxygen Species in Microvascular Remodeling. Csanyi G, vol.15, pp.23792-23835, 2014.

J. Delourme, C. Delattre, P. Godard, F. Steenhouwer, and N. Just, Conséquences respiratoires de l'inhalation d'herbe de cannabis frelatée Revue des Maladies RespiratoiresVol 26, pp.552-556, 2009.

D. Ravi, M. Ghasemiesfe, and D. Korenstein, Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review, 2018.
DOI : 10.7326/m17-1548

, Ann Intern Med

T. B. Rajavashisth, M. Shaheen, K. C. Norris, D. Pan, S. K. Sinha et al., Decreased prevalence of diabetes in marijuana users: crosssectional data from the National Health and Nutrition Examination Survey (NHANES) III, BMJ Open, vol.2, p.494, 2012.

D. C. Vidot, G. Prado, W. M. Hlaing, K. L. Arheart, and S. E. Messiah, Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk, J Addict Dis, vol.33, pp.1-8, 2014.

E. A. Penner, H. Buettner, and M. A. Mittleman, The impact of marijuana use on glucose, insulin, and insulin resistance among US adults, Am J Med, vol.126, pp.583-592, 2013.

M. P. Bancks, M. J. Pletcher, S. G. Kertesz, S. Sidney, J. S. Rana et al., Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study, Diabetologia, vol.58, pp.2736-2780, 2015.

R. Muniyappa, S. Sable, R. Ouwerkerk, A. Mari, A. M. Gharib et al., Metabolic effects of chronic cannabis smoking, Diabetes Care, vol.36, pp.2415-2437, 2013.
DOI : 10.2337/dc12-2303

URL : http://care.diabetesjournals.org/content/36/8/2415.full.pdf

N. Rodondi, M. J. Pletcher, K. Liu, and S. B. Hulley, Sidney S; Coronary Artery Risk Development in Young Adults (CARDIA) Study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study), Am J Cardiol, vol.98, pp.478-84, 2006.

A. K. Danielsson, A. Lundin, A. Yaregal, C. G. O¨stensono¨stenson, P. Allebeck et al., Cannabis use as risk or protection for type 2 diabetes: a longitudinal study, vol.18, p.0

, Swedish men and women, J Diabetes Res, p.6278709, 2016.

M. R. Hayatbakhsh, M. J. O'callaghan, A. A. Mamun, G. M. Williams, A. Clavarino et al., Cannabis use and obesity and young adults, American Journal of Drug and Alcohol Abuse, vol.36, issue.6, pp.350-356, 2010.
DOI : 10.3109/00952990.2010.500438

G. Ngueta, R. E. Beíanger, E. A. Laouan-sidi, and M. Lucas, Cannabis use in relation to obesity and insulin resistance in the Inuit population, Obesity (Silver Spring), vol.23, pp.290-295, 2015.

M. Warren, K. Frost-pineda, and M. Gold, Body mass index and marijuana use, Journal of Addictive Diseases, vol.24, issue.3, pp.95-100, 2005.

M. E. Wall, B. M. Sadler, D. Brine, H. Taylor, and M. Perez-reyes, Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women, Clin Pharmacol Ther, vol.34, pp.352-363, 1983.

R. M. Craft, J. A. Marusich, and J. L. Wiley, Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system? Life sciences, vol.92, pp.476-481, 2013.

F. Mach, F. Montecucco, and S. Steffens, Cannabinoid receptors in acute and chronic complications of atherosclerosis, British Journal of Pharmacology, vol.153, issue.2, pp.290-298, 2008.

F. Busse, L. Omidi, K. Timper, A. Leichtle, M. Windgassen et al., Lead poisoning due to adulterated marijuana, N Engl J Med, vol.358, issue.15, pp.1641-1643, 2008.
DOI : 10.1056/nejmc0707784

A. Caligiani, G. Palla, and B. Bernardelli, GC-MS analysis of hashish samples: a case of adulteration with colophony, Journal of Forensic Sciences, vol.51, pp.1096-1100, 2006.

L. A. Malit, R. E. Johnstone, D. I. Bourke, R. A. Kulp, and V. Klein,

C. Smith, 127) « Intravenous Delta9Tetrahydrocannabinol: Effects of Ventilatory Control and Cardiovascular Dynamics

D. Engelbert, H. G. Kress, B. Kraft, A. Sibylle, and . Kozek-langenecker,